Eton Pharmaceuticals, Inc. (ETON): Price and Financial Metrics

Eton Pharmaceuticals, Inc. (ETON): $12.57

0.29 (+2.36%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ETON to Watchlist
Sign Up

ETON Price/Volume Stats

Current price $12.57 52-week high $13.98
Prev. close $12.28 52-week low $3.03
Day low $12.17 Volume 281,500
Day high $13.29 Avg. volume 108,801
50-day MA $10.30 Dividend yield N/A
200-day MA $5.61 Market Cap 327.46M

ETON Stock Price Chart Interactive Chart >


Eton Pharmaceuticals, Inc. (ETON) Company Bio


Eton Pharmaceuticals Inc. Eton Pharmaceuticals, Inc. is a is a specialty pharmaceutical company, which is focused on developing and commercializing pharmaceutical products. It products include EM-100, ET-103, CT-100, DS-300, DS-200, and DS-100. The Company focuses on product candidates that are liquid in formulation, including injections, oral liquids and ophthalmics. EM-100 is an ophthalmic product with a preservative-free formulation of the active ingredient ketotifen, and is indicated for the treatment of allergic conjunctivitis. ET-103 is an oral liquid formulation of levothyroxine, which is widely used in tablet and capsule form, and is indicated for the treatment of hypothyroidism. CT-100 is our patent-pending synthetic corticotropin therapeutic candidate that mimics the amino acid chain of injectable product H.P. Acthar Gel. DS-300 is a patent-pending injectable product candidate indicated to treat nutritional deficiencies. DS-200 is an injectable product candidate indicated to treat pain management.


ETON Latest News Stream


Event/Time News Detail
Loading, please wait...

ETON Latest Social Stream


Loading social stream, please wait...

View Full ETON Social Stream

ETON Price Returns

1-mo 11.93%
3-mo 115.61%
6-mo 283.23%
1-year 173.86%
3-year 195.07%
5-year 79.70%
YTD 186.99%
2023 55.32%
2022 -34.27%
2021 -47.23%
2020 12.92%
2019 17.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!